Hypoimmune stem cells and islets: hype or a true breakthrough in diabetes treatment?
Abstract Immune-resistant pancreatic islets hold great promise for advancing diabetes cell therapy. Two key approaches, hypoimmunogenic pluripotent stem cells (PSCs) and hypoimmunogenic cadaveric islets, aim to overcome immune rejection in islet transplantation. Human PSCs provide a versatile source...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2025-10-01
|
| Colección: | Cellular & Molecular Biology Letters |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s11658-025-00786-8 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|